Published in PLoS One on June 20, 2016
Ultrasound-mediated transdermal protein delivery. Science (1995) 2.07
Thresholds for transient cavitation produced by pulsed ultrasound in a controlled nuclei environment. J Acoust Soc Am (1990) 2.00
Prospects for research in diabetes mellitus. JAMA (2001) 1.45
Transdermal drug delivery using low-frequency sonophoresis. Pharm Res (1996) 1.42
Low-frequency sonophoresis: current status and future prospects. Adv Drug Deliv Rev (2008) 1.42
Acoustic cavitation: a possible consequence of biomedical uses of ultrasound. Br J Cancer Suppl (1982) 1.38
Low-frequency sonophoresis: a review. Adv Drug Deliv Rev (2004) 1.30
Ultrasound mediated transdermal insulin delivery in pigs using a lightweight transducer. Pharm Res (2007) 1.28
An investigation of the role of cavitation in low-frequency ultrasound-mediated transdermal drug transport. Pharm Res (2002) 1.23
Investigations of the role of cavitation in low-frequency sonophoresis using acoustic spectroscopy. J Pharm Sci (2002) 1.18
Contrast echocardiography: new agents. Ultrasound Med Biol (2004) 1.17
In vivo skin optical clearing by glycerol solutions: mechanism. J Biophotonics (2010) 1.13
Interactions of inertial cavitation bubbles with stratum corneum lipid bilayers during low-frequency sonophoresis. Biophys J (2003) 1.12
Ultrasonic characterization of ultrasound contrast agents. Med Biol Eng Comput (2009) 1.08
On the suitability of broadband attenuation measurement for characterizing contrast microbubbles. Ultrasound Med Biol (2005) 1.04
Sonophoresis. II. Examination of the mechanism(s) of ultrasound-enhanced transdermal drug delivery. Pharm Res (1992) 1.00
A physical method to enhance transdermal delivery of a tissue optical clearing agent: combination of microneedling and sonophoresis. Lasers Surg Med (2010) 1.00
Optical clearing of human skin: comparative study of permeability and dehydration of intact and photothermally perforated skin. J Biomed Opt (2008) 0.99
Perspectives on transdermal ultrasound mediated drug delivery. Int J Nanomedicine (2007) 0.93
Acoustic cavitation as an enhancing mechanism of low-frequency sonophoresis for transdermal drug delivery. Biol Pharm Bull (2009) 0.92
Therapeutic ultrasound an overview. Ultrason Sonochem (2011) 0.91
Sonophoresis in transdermal drug deliverys. Ultrasonics (2013) 0.91
Recovery of skin barrier properties after sonication in human subjects. Ultrasound Med Biol (2009) 0.91
Characterization of Definity™ ultrasound contrast agent at frequency range of 5-15 MHz. Ultrasound Med Biol (2011) 0.89
Ultrasound mediated transdermal drug delivery. Adv Drug Deliv Rev (2014) 0.89
In vitro study of low-frequency ultrasound-enhanced transdermal transport of fentanyl and caffeine across human and hairless rat skin. Int J Pharm (2001) 0.89
How do microbubbles and ultrasound interact? Basic physical, dynamic and engineering principles. Curr Pharm Des (2012) 0.86
Transdermal drug delivery aided by an ultrasound contrast agent: an in vitro experimental study. Open Biomed Eng J (2010) 0.86
Sonophoresis using ultrasound contrast agents for transdermal drug delivery: an in vivo experimental study. Ultrasound Med Biol (2012) 0.85
Combined effect of low-frequency ultrasound and iontophoresis: applications for transdermal heparin delivery. Pharm Res (2000) 0.84
Sonoporation induces apoptosis and cell cycle arrest in human promyelocytic leukemia cells. Ultrasound Med Biol (2011) 0.84
Dependence of optimal seed bubble size on pressure amplitude at therapeutic pressure levels. Ultrasonics (2010) 0.83
Comparison of bovine udder skin with human and porcine skin in percutaneous permeation experiments. Altern Lab Anim (2006) 0.83
Property and contrast-enhancement effects of lipid ultrasound contrast agent: a preliminary experimental study. Ultrasound Med Biol (2005) 0.79
Simultaneous analysis of glycyrrhizin, paeoniflorin, quercetin, ferulic acid, liquiritin, formononetin, benzoic acid and isoliquiritigenin in the Chinese proprietary medicine Xiao Yao Wan by HPLC. J Pharm Biomed Anal (2007) 0.77
Synthesis of laboratory Ultrasound Contrast Agents. Molecules (2013) 0.76